Cargando…
System Dynamics Modeling Can be Leveraged to Predict Critical Care Pathways and Costs for End Stage Renal Disease: US Population to 2020
Background: End Stage Renal Disease (ESRD) accounts for 9% of Medicare spending, with the beneficiaries suffering from ESRD costing 7-9 times more than the average. This population is expected to continue to grow as a portion of Medicare beneficiaries. To provide clinicians and administrators with a...
Autores principales: | Fernandez, Luca, Koliba, Christopher, Zia, Asim, Cheung, Katharine, Solomon, Richard, Jones, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471390/ https://www.ncbi.nlm.nih.gov/pubmed/37662658 http://dx.doi.org/10.36469/9839 |
Ejemplares similares
-
Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
por: Blanchette, Christopher M., et al.
Publicado: (2014) -
High Costs of Dialysis Transportation in the United States: Exploring Approaches to a More Cost-effective Delivery System
por: Stephens, J. Mark, et al.
Publicado: (2013) -
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
por: Stahmeyer, Jona T., et al.
Publicado: (2013) -
Cost-effectiveness of Chloride-liberal versus Chloriderestrictive Intravenous Fluids among Patients Hospitalized in the United States
por: Perrault, Louise, et al.
Publicado: (2016) -
Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients
por: Koyner, Jay L., et al.
Publicado: (2023)